Cover Image
市場調查報告書

內皮層功能障礙:全球臨床實驗檢討

Endothelial Dysfunction Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 312392
出版日期 內容資訊 英文 84 Pages
訂單完成後即時交付
價格
Back to Top
內皮層功能障礙:全球臨床實驗檢討 Endothelial Dysfunction Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月06日 內容資訊: 英文 84 Pages
簡介

本報告提供內皮層功能障礙的治療藥相關臨床實驗調查分析,提供您最新趨勢,各階段及Phase狀況,有潛力的企業,開發中的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:心血管系統臨床實驗上內皮層功能障礙的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:心血管系統臨床實驗上內皮層功能障礙的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

各類贊助商臨床實驗

有潛力的贊助商

  • 內皮層功能障礙治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • BioMarin Pharmaceutical Inc.
    • 武田藥品工業
    • Sanofi
    • Nestle S.A.
    • Gilead Sciences, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Defense Medical College
    • Mayo Clinic
    • Radboud University
    • Boston University
    • Gulhane School of Medicine
    • 岡山大學大學院醫生牙齒藥學綜合研究科
    • Vanderbilt University
    • University of Dundee
    • Emory University
    • UMC Utrecht Holding BV

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2580CTIDB

GlobalData's clinical trial report, "Endothelial Dysfunction Global Clinical Trials Review, H1, 2015" provides data on the Endothelial Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endothelial Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endothelial Dysfunction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Endothelial Dysfunction
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Endothelial Dysfunction
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Endothelial Dysfunction Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • BioMarin Pharmaceutical Inc.
      • Clinical Trial Overview of BioMarin Pharmaceutical Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Nestle S.A.
      • Clinical Trial Overview of Nestle S.A.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • National Defense Medical College
      • Clinical Trial Overview of National Defense Medical College
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • Boston University
      • Clinical Trial Overview of Boston University
      • Gulhane School of Medicine
      • Clinical Trial Overview of Gulhane School of Medicine
      • Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
      • Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • University of Dundee
      • Clinical Trial Overview of University of Dundee
      • Emory University
      • Clinical Trial Overview of Emory University
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Defense Medical College, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gulhane School of Medicine, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015*

List of Figures

  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top